ATC Group: A06AX03 Lubiprostone

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AX03 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Laxatives
3
Laxatives
4
Other laxatives
5
A06AX03
Lubiprostone

Active ingredients in A06AX03

Active Ingredient
Description

Lubiprostone is a locally acting chloride channel activator that enhances a chloride-rich intestinal fluid secretion without altering sodium and potassium concentrations in the serum. By increasing intestinal fluid secretion, lubiprostone increases motility in the intestine, thereby facilitating the passage of stool and alleviating symptoms associated with chronic idiopathic constipation (CIC).

Medicines in this ATC group

Drug
Countries

Brazil Japan Singapore United States

Ecuador

Related product monographs

Title
Type
Country
Structured Product Labeling (SPL/PLR)
US